← Open Payments lookup

CODY MYGRANT: Open Payments

NPI 1528435153 · ODESSA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,546 in 49 payments from 9 companies in 2025. Trend: 2023 $1,023 · 2024 $1,252 · 2025 $1,546

Food & beverage: $1,546
CompanyPaymentsAmount
Ethicon US, LLC14$504
Lilly USA, LLC12$236
Novo Nordisk Inc9$224
AstraZeneca Pharmaceuticals LP4$188
ABBVIE INC.3$130
Smith+Nephew, Inc.3$117
Boehringer Ingelheim Pharmaceuticals, Inc.1$90
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$34
Pacira Pharmaceuticals Incorporated1$22

Products named: STRATAFIX, MOUNJARO, FARXIGA, Ozempic, VISTASEAL, ZEPBOUND, Harmonic, QULIPTA.

Industry payments across TX — which companies pay providers there.